PL2119700T3 - Pochodna benzyloaminy lub jej farmaceutycznie dopuszczalna sól addycyjna z kwasem oraz ich zastosowanie do celów medycznych - Google Patents

Pochodna benzyloaminy lub jej farmaceutycznie dopuszczalna sól addycyjna z kwasem oraz ich zastosowanie do celów medycznych

Info

Publication number
PL2119700T3
PL2119700T3 PL08704230T PL08704230T PL2119700T3 PL 2119700 T3 PL2119700 T3 PL 2119700T3 PL 08704230 T PL08704230 T PL 08704230T PL 08704230 T PL08704230 T PL 08704230T PL 2119700 T3 PL2119700 T3 PL 2119700T3
Authority
PL
Poland
Prior art keywords
pharmaceutically acceptable
acid addition
addition salt
acceptable acid
medical purposes
Prior art date
Application number
PL08704230T
Other languages
English (en)
Inventor
Ryoji Hayashi
Tsukasa Kikuchi
Masaki Arai
Satoshi Kurosawa
Ko Hasebe
Sayoko Kanie
Seiichiro Ozono
Atsushi Otsuka
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of PL2119700T3 publication Critical patent/PL2119700T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL08704230T 2007-01-31 2008-01-31 Pochodna benzyloaminy lub jej farmaceutycznie dopuszczalna sól addycyjna z kwasem oraz ich zastosowanie do celów medycznych PL2119700T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007020582 2007-01-31
EP08704230A EP2119700B1 (en) 2007-01-31 2008-01-31 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
PCT/JP2008/051479 WO2008093767A1 (ja) 2007-01-31 2008-01-31 ベンジルアミン誘導体またはその薬学的に許容される酸付加塩、およびその医薬用途

Publications (1)

Publication Number Publication Date
PL2119700T3 true PL2119700T3 (pl) 2013-01-31

Family

ID=39674074

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08704230T PL2119700T3 (pl) 2007-01-31 2008-01-31 Pochodna benzyloaminy lub jej farmaceutycznie dopuszczalna sól addycyjna z kwasem oraz ich zastosowanie do celów medycznych

Country Status (12)

Country Link
US (1) US8148427B2 (pl)
EP (1) EP2119700B1 (pl)
JP (1) JP4720909B2 (pl)
KR (1) KR101479048B1 (pl)
CN (1) CN101595088B (pl)
AU (1) AU2008210637B2 (pl)
CA (1) CA2677061C (pl)
DK (1) DK2119700T3 (pl)
ES (1) ES2387586T3 (pl)
PL (1) PL2119700T3 (pl)
PT (1) PT2119700E (pl)
WO (1) WO2008093767A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8198330B2 (en) * 2008-07-31 2012-06-12 Toray Industries, Inc. Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid addition salt thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB993584A (pl) 1962-01-24
US5776983A (en) 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
ATE266639T1 (de) 1997-10-17 2004-05-15 Yamanouchi Pharma Co Ltd Amidderivate oder deren salze
EP1070046A1 (en) 1998-04-06 2001-01-24 Fujisawa Pharmaceutical Co., Ltd. Propanolamine derivatives
US6436914B1 (en) * 1998-06-30 2002-08-20 Bristol-Myers Squibb Company 2-hydroxy-3—(4-hydroxy-3-sulfonamidophenyl)—propylamines useful as beta 3 adrenergic agonists
CN1349502A (zh) 1999-04-01 2002-05-15 旭化成株式会社 经由叠氮化物制备三环氨基－醇衍生物的新方法
US6514991B2 (en) * 2000-07-17 2003-02-04 Wyeth Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists
PE20040950A1 (es) * 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
WO2005040093A1 (ja) 2003-10-24 2005-05-06 Kissei Pharmaceutical Co., Ltd. アミノアルコール誘導体、それを含有する医薬組成物およびそれらの用途

Also Published As

Publication number Publication date
PT2119700E (pt) 2012-10-02
AU2008210637A1 (en) 2008-08-07
ES2387586T3 (es) 2012-09-26
EP2119700A1 (en) 2009-11-18
CN101595088B (zh) 2013-06-19
US20100099769A1 (en) 2010-04-22
AU2008210637B2 (en) 2012-08-16
DK2119700T3 (da) 2012-10-22
JPWO2008093767A1 (ja) 2010-05-20
CA2677061C (en) 2014-07-29
EP2119700A4 (en) 2011-06-08
US8148427B2 (en) 2012-04-03
WO2008093767A1 (ja) 2008-08-07
KR20090104815A (ko) 2009-10-06
EP2119700B1 (en) 2012-08-01
CA2677061A1 (en) 2008-08-07
KR101479048B1 (ko) 2015-01-05
JP4720909B2 (ja) 2011-07-13
CN101595088A (zh) 2009-12-02

Similar Documents

Publication Publication Date Title
HUS000509I2 (hu) Abemaciklib vagy egy gyógyászatilag elfogadható sója
IL207080A0 (en) Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
PL2371853T3 (pl) Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, kompozycja farmaceutyczna, zastosowanie pochodnej insuliny lub jej farmaceutycznie dopuszczalnej soli oraz sposób leczenia
IL207078A0 (en) Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
IL204663A0 (en) Nicotinamide derivatives, preparastion thereof and therapeutic use thereof
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
ZA201100210B (en) Pyridino-pyridinone derivatives,preparation thereof,and therapeutic use thereof
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
EP2157093A4 (en) HETEROCYCLIC PYRROLO-NITROGEN-DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL USE
IL216967B (en) The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases
PL2146991T3 (pl) Pochodne triazolopirydyno-karboksamidów, ich wytwarzanie i zastosowanie terapeutyczne
SI2137141T1 (sl) Arilamidi bifenil-4-il-sulfonske kisline in njihova uporaba kot terapevtska sredstva
EP2009006A4 (en) UREIDE DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
IL217293A0 (en) NOVEL 1,2,3,4 - TETRAHYDROPYRIMIDO {1,2-a} PYRIMIDIN - 6 - ONE DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF
PL2196206T3 (pl) Środek do łagodzenia problemów skórnych zawierający pochodną morfinanu lub jego farmakologicznie dopuszczalną kwasową sól addycyjną jako substancję czynną
ZA201200585B (en) "indole derivative and pharmaceutically acceptable salt thereof"
IL219888A0 (en) Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
EP2091480A4 (en) SYSTEM FOR THE TREATMENT OF HEART TISSUE
IL217300A0 (en) Pyrazole derivatives' prepartion thereof, and therapeutic use thereof
IL212830A0 (en) Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
PL1988090T3 (pl) Pochodne kwasu imidazolo-5-karboksylowego, sposoby przygotowania i ich zastosowanie
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
ZA201108106B (en) Use of phthalimide derivatives in the treatment of diseases
IL209903A0 (en) Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same